Published • loading... • Updated
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
Summary by The Hamilton Spectator
7 Articles
7 Articles
Hastings Tribune+6 Reposted by 6 other sources
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
TORONTO and HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune diseases, today announced the voting results from the Company’s…
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left2Leaning Right2Center2Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
